Literature DB >> 2475577

Lack of immunodominance in the T cell response to herpes simplex virus glycoprotein D after administration of infectious virus.

K Yamashita1, E Heber-Katz.   

Abstract

Glycoprotein D (gD) of HSV has been shown to be a potent immunogen. To analyze the T cell antigenic determinants on gD, a series of 28 overlapping 20-mer peptides that span the extracellular portion of gD-1 were examined for their ability to stimulate T cells from rgD-1 or infectious HSV-1-primed H-2d mice in vitro. rgD-1-primed cells responded exclusively to peptide 241-260, the immunodominant determinant of gD in H-2d mice. In contrast, infectious HSV-primed T cells were shown to respond to 17 (and up to 22) of 28 synthetic gD peptides. These results indicate an extensive diversity in the T cell repertoire to gD in H-2d mice with T cells directed to a broad array of peptide determinants being recruited during the acute phase of an HSV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475577      PMCID: PMC2189426          DOI: 10.1084/jem.170.3.997

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  11 in total

1.  Class I major histocompatibility complex-restricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin.

Authors:  T J Braciale; M T Sweetser; L A Morrison; D J Kittlesen; V L Braciale
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 2.  The choice of T-cell epitopes utilized on a protein antigen depends on multiple factors distant from, as well as at the determinant site.

Authors:  G Gammon; N Shastri; J Cogswell; S Wilbur; S Sadegh-Nasseri; U Krzych; A Miller; E Sercarz
Journal:  Immunol Rev       Date:  1987-08       Impact factor: 12.988

3.  Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.

Authors:  D Long; T J Madara; M Ponce de Leon; G H Cohen; P C Montgomery; R J Eisenberg
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

4.  The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.

Authors:  L Sanchez-Pescador; R L Burke; G Ott; G Van Nest
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

5.  A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: antibody and T-cell activity to several influenza hemagglutinin synthetic sites.

Authors:  M Z Atassi; J Kurisaki
Journal:  Immunol Commun       Date:  1984

6.  Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.

Authors:  J F Rooney; C Wohlenberg; K J Cremer; B Moss; A L Notkins
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2.

Authors:  E Watari; B Dietzschold; G Szokan; E Heber-Katz
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

8.  Extensive diversity in the recognition of influenza virus hemagglutinin by murine T helper clones.

Authors:  K H Mills; J J Skehel; D B Thomas
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

9.  Class II major histocompatibility complex-restricted T cells specific for a virion structural protein that do not recognize exogenous influenza virus. Evidence that presentation of labile T cell determinants is favored by endogenous antigen synthesis.

Authors:  L C Eisenlohr; C J Hackett
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

10.  Mechanisms influencing the immunodominance of T cell determinants.

Authors:  L Adorini; E Appella; G Doria; Z A Nagy
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

View more
  12 in total

1.  Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.

Authors:  Y Yanagi; A Tishon; H Lewicki; B A Cubitt; M B Oldstone
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  Roles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.

Authors:  G S Hui; A Hashimoto; S P Chang
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice.

Authors:  W Gerhard; A M Haberman; P A Scherle; A H Taylor; G Palladino; A J Caton
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 4.  The interplay of T cell responses to viral and autoimmune epitopes.

Authors:  E Heber-Katz
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

5.  From Immunity and Vaccines to Mammalian Regeneration.

Authors:  Ellen Heber-Katz
Journal:  J Infect Dis       Date:  2015-07-15       Impact factor: 5.226

6.  Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.

Authors:  Xiuli Zhang; Florence A Castelli; Xiaoming Zhu; Michele Wu; Bernard Maillère; Lbachir BenMohamed
Journal:  Clin Vaccine Immunol       Date:  2008-07-30

7.  Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.

Authors:  Lbachir BenMohamed; Georges Bertrand; Cory D McNamara; Helene Gras-Masse; Juergen Hammer; Steven L Wechsler; Anthony B Nesburn
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.

Authors:  Min Kim; Janette Taylor; John Sidney; Zorka Mikloska; Neil Bodsworth; Katerina Lagios; Heather Dunckley; Karen Byth-Wilson; Martine Denis; Robert Finlayson; Rajiv Khanna; Alessandro Sette; Anthony L Cunningham
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

9.  Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.

Authors:  G S Hui; C Nikaido; C Hashiro; D C Kaslow; W E Collins
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

10.  T cell responses to synthetic peptides of herpes simplex virus type 1 glycoprotein D in naturally infected individuals.

Authors:  R A Damhof; J W Drijfhout; A J Scheffer; J B Wilterdink; G W Welling; S Welling-Wester
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.